GRDN Guardian Pharmacy Services Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: GRDN

Price (delayed)

$40.86

Market cap

$2.59B

P/E Ratio

48.07

Dividend/share

N/A

EPS

$0.85

Enterprise value

$2.56B

?
Relative Growth: Rel. Growth: 26
Relative Strength: Rel. Strength: 80
Relative Valuation: Rel. Valuation: 41
Relative Profitability: Rel. Profitability: 78

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of long-term health care facilities (“LTCFs”) adhere to their ...

Highlights
GRDN's net income has surged by 153% year-on-year and by 8% since the previous quarter
GRDN's quick ratio is up by 43% year-on-year and by 6% since the previous quarter
The debt is up by 30% YoY
Sector: Healthcare
Industry: Medical Care Facilities
Website: https://guardianpharmacy.com
Peers: CVS MCK COR CAH

Key stats

What are the main financial stats of GRDN

GRDN stock price

How has the Guardian Pharmacy Services stock price performed over time
Intraday
4.39%
1 week
5.45%
1 month
11.52%
1 year
89.96%
YTD
35.79%
QTD
8.5%

Financial performance

How have Guardian Pharmacy Services's revenue and profit performed over time
Revenue
$1.46B
Gross profit
$304.68M
Operating income
$78.76M
Net income
$53.07M
Gross margin
20.9%
Net margin
3.6%
GRDN's net income has surged by 153% year-on-year and by 8% since the previous quarter
The net margin has soared by 146% YoY and by 6% QoQ
GRDN's gross profit is up by 20% year-on-year and by 4.1% since the previous quarter
GRDN's revenue is up by 14% year-on-year

Price vs fundamentals

How does GRDN's price correlate with its fundamentals

Growth

What is Guardian Pharmacy Services's growth rate over time

Valuation

What is Guardian Pharmacy Services stock price valuation
P/E
48.07
P/B
11.71
P/S
1.78
EV/EBIT
32.36
EV/EBITDA
25.06
EV/Sales
1.76
The EPS has increased by 8% since the previous quarter
GRDN's equity is up by 42% year-on-year and by 7% since the previous quarter
The P/B is 21% above the last 4 quarters average of 9.3
GRDN's price to sales (P/S) is 31% higher than its last 4 quarters average of 1.3
GRDN's revenue is up by 14% year-on-year

Efficiency

How efficient is Guardian Pharmacy Services business performance
The ROIC has soared by 187% YoY and by 2% from the previous quarter
The return on sales has surged by 177% year-on-year and by 6% since the previous quarter
GRDN's ROA has soared by 144% YoY
GRDN's ROE has soared by 130% year-on-year

Dividends

What is GRDN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for GRDN.

Financial health

How did Guardian Pharmacy Services financials performed over time
GRDN's total assets is 119% greater than its total liabilities
GRDN's quick ratio is up by 43% year-on-year and by 6% since the previous quarter
GRDN's current ratio is up by 28% year-on-year and by 6% since the previous quarter
The debt is 83% lower than the equity
GRDN's equity is up by 42% year-on-year and by 7% since the previous quarter
The debt is up by 30% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.